Skip to main navigation
Main navigation
About Us
Overview
Board of Directors
Founders
Management
Values
The Science
Publications
Pipeline
Overview
Lead Product Candidates
Clinical Trials
UBX1325
Patients
Clinical Trial Access
Investors & Media
Company Overview
Press Releases
Events & Presentations
Corporate Governance
Governance Documents
Board of Directors
Executive Team
Committee Composition
SEC Filings
SEC Fillings
Annual Reports
Stock Information
Stock Quote & Chart
Historic Price Lookup
Investor Resources
Work with Us
Overview
Open Positions
Contact Us
Investors & Media
Phase 2 BEHOLD Program Update Call
Nov 1, 2022 at 8:00 AM EDT
Click here for webcast
